Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death

R. Warsame, S. K. Kumar, M. A. Gertz, M. Q. Lacy, F. K. Buadi, S. R. Hayman, N. Leung, D. Dingli, J. A. Lust, R. P. Ketterling, Y. Lin, S. Russell, L. Hwa, P. Kapoor, R. S. Go, S. R. Zeldenrust, R. A. Kyle, S. V. Rajkumar, A. Dispenzieri

Research output: Contribution to journalArticle

5 Scopus citations


Importance of interphase fluorescent in situ hybridization (FISH) with cytoplasmic staining of immunoglobulin FISH (cIg-FISH) on bone marrow is not well understood in light chain amyloidosis (AL). This is in contrast with multiple myeloma where prognostic and treatment related decisions are dependent on cytogenetic testing. This retrospective study reviewed 401 AL patients with cIg-FISH testing performed at our institution between 2004 and 2012. Eighty-one percent of patients had an abnormal cIg-FISH. Common abnormalities involved translocations of chromosome 14q32 (52%), specifically: t(11;14) (43%), t(14;16) (3%) and t(4;14) (2%). Other common abnormalities include monosomy 13/deletion 13q (30%), trisomies 9 (20%), 15 (14%), 11 (10%) and 3 (10%). Median overall survival for this cohort of patients is 3.5 years. When plasma cell burden was greater than 10% trisomies predicted for worse survival (44 vs 19 months), and when it was ≥10% t(11;14) predicted for worse survival (53 months vs not reached). Abnormal cIg-FISH was significantly associated with advanced cardiac involvement, and remained a prognostic factor on multivariate analysis. This large AL cohort demonstrates that abnormal FISH at diagnosis is prognostic for survival and advanced cardiac disease. Particularly, trisomies and t(11;14) affect survival when degree of plasma cell burden is considered.

Original languageEnglish (US)
Article numbere310
JournalBlood cancer journal
Issue number5
StatePublished - May 1 2015


ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this